Beclomethasone versus budesonide for chronic asthma

Cochrane Database of Systematic Reviews

Volumn 2002, Issue 1, 2002, Pages

  Adams, Nick P ^a   Bestall, Janine C ^b   Jones, Paul ^c  

^a UK   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; HYDROCORTISONE; ANTIASTHMATIC AGENT; BRONCHODILATING AGENT;

ASTHMA; BRONCHUS HYPERREACTIVITY; CLINICAL OUTCOME; COMPARATIVE STUDY; COUGHING; DISEASE CONTROL; DISEASE EXACERBATION; DRUG DELIVERY SYSTEM; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG USE; DYSPNEA; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HYDROCORTISONE BLOOD LEVEL; META ANALYSIS; METHODOLOGY; PARALLEL DESIGN; PEAK EXPIRATORY FLOW; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCORING SYSTEM; SPIROMETRY; SYMPTOM; SYSTEMATIC REVIEW; WHEEZING; ADULT; CHILD; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; INHALATIONAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, INHALATION; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; BECLOMETHASONE; BRONCHODILATOR AGENTS; BUDESONIDE; CHILD; CHRONIC DISEASE; HUMANS; RANDOMIZED CONTROLLED TRIALS;

EID: 0036357522     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD003530     Document Type: Review

References (48)

1. Baran D. A comparison of inhaled budesonide and beclomethasone dipropionate in childhood asthma. British Journal of Diseases of the Chest 1987;81(2):170-5.
2. Bisgaard H, Damkjaer Nielsen M, Andersen B, Andersen P, Foged N, Fuglsang G, et al. Adrenal function in children with bronchial asthma treated with beclomethasone dipropionate or budesonide. Journal of Allergy & Clinical Immunology 1988;81(6):1088-95.
3. Bjorkander J, Formgren H, Johansson SA, Millqvist E. Methodological aspects on clinical trials with inhaled corticosteroids: results of two comparisons between two steroid aerosols in patients with asthma. European Journal of Respiratory Diseases - Supplement 1982;122:108-17.
4. Boe J, Rosenhall L, Alton M, Carlsson LG, Carlsson U, Hermansson BA, et al. Comparison of dose-response effects of inhaled beclomethasone dipropionate and budesonide in the management of asthma. Allergy: European Journal of Allergy & Clinical Immunology 1989;44(5):349-55.
5. Brambilla C, Godard P, Lacronique J, Allaert FA, Duroux P, Blaive B, et al. A 3-month comparative dose-reduction study with inhaled beclomethasone dipropionate and budesonide in the management of moderate to severe adult asthma. Drug Investigation 1994;8(1):49-56.
6. Dal Negro R, Micheletto C, Ciani F, Muzzi A, Crimi E, Filippa P, et al. Efficacy and safety of inhaled beclomethasone dipropionate dry powder in the treatment of chronic asthma: A controlled study vs. budesonide. European Respiratory Journal. 1997:351S.
7. Ebden P, Jenkins A, Houston G, Davies BH. Comparison of two high dose corticosteroid aerosol treatments, beclomethasone dipropionate (1500 micrograms/day) and budesonide (1600 micrograms/day), for chronic asthma. Thorax 1986;41(11):869-74.
8. Field HV, Jenkinson PM, Frame MH, Warner JO. Asthma treatment with a new corticosteroid aerosol, budesonide, administered twice daily by spacer inhaler. Archives of Disease in Childhood 1982;57(11):864-6.
9. Greefhorst APM. Budesonide and terbutaline delivered via Turbuhaler compared to BDP and salbutamol delivered via Rotahaler. European Respiratory Journal. 1992; Vol. 5, issue Suppl 15:360S.
10. Hamalainen KM, Laurikaninen K, Leinonen M, Jager L. Comparison of two multidose powder inhalers (MDPI) in the treatment of asthma with inhaled corticosteroids. European Respiratory Journal. 1998:61S.
11. Keelan P, Gray P, Kelly P, Frame M. Comparison of a new corticosteroid aerosol, budesonide, with beclomethasone dipropionate in the treatment of chronic asthma. Irish Medical Journal 1984;77(8):244-7.
12. Micheletto C, Mauroner L, Burti E, Turco P, Pomari L, Cantini L, Dal Negro R. Inhaled beclomethasone dipropionate and budesonide dry powder in chronic asthma: Lung function-serum ECP relationship. European Respiratory Journal. 1997:351S.
13. Nicolaizik WH, Marchant JL, Preece MA, Warner JO. Endocrine and lung function in asthmatic children on inhaled corticosteroids. American Journal of Respiratory & Critical Care Medicine 1994;150(3):624-8.
14. Pedersen S, Fuglsang G. Urine cortisol excretion in children treated with high doses of inhaled corticosteroids: a comparison of budesonide and beclomethasone. European Respiratory Journal 1988;1(5):433-5.
15. Petrie GR, Choo-Kang YFJ, Clark RA, Milledge JSSPR, Whitfield RJ, Higgins AJ. An assessment of the acceptability of two breath-actuated corticosteroid inhalers comparison of Turbohaler(TM) with Diskhaler(TM). Drug Investigation 1990;2(2):129-31.
16. Rafferty P, Tucker LG, Frame MH, Fergusson RJ, Biggs BA, Crompton GK. Comparison of budesonide and beclomethasone dipropionate in patients with severe chronic asthma: assessment of relative prednisolone-sparing effects. British Journal of Diseases of the Chest 1985;79(3):244-50.
17. Selroos O, Backman R, Forsen KO, Lofroos AB, Niemisto M, Pietinalho A, et al. Clinical efficacy of budesonide Turbuhaler compared with that of beclomethasone dipropionate pMDI with volumatic spacer. A 2-year randomized study in 102 asthma patients. Allergy: European Journal of Allergy & Clinical Immunology 1994;49(10):833-6.
18. Springer C, Avital A, Maayan C, Rosler A, Godfrey S. Comparison of budesonide and beclomethasone dipropionate for treatment of asthma. Archives of Disease in Childhood 1987;62(8):815-9.
19. Stiksa G, Glennow C, Johannesson N. A open cross-over trial with budesonide and beclomethasone dipropionate in patients with bronchial asthma. European Journal of Respiratory Diseases - Supplement 1982;122:266-7.
20. Stiksa G, Glennow C, Johannesson N. A open cross-over trial with budesonide and beclomethasone dipropionate in patients with bronchial asthma. European Journal of Respiratory Diseases - Supplement 1982;122:266-7.
21. Stiksa G, Glennow C. Once daily inhalation of budesonide in the treatment of chronic asthma: a clinical comparison. Annals of Allergy 1985;55(1):49-51.
22. Svendsen UG, Frolund L, Heinig JH, Madsen F, Nielsen NH, Weeke B. High-dose inhaled steroids in the management of asthma. A comparison of the effects of budesonide and beclomethasone dipropionate on pulmonary function, symptoms, bronchial responsiveness and the adrenal function. Allergy: European Journal of Allergy and Clinical Immunology 1992;47(2 Pt 2):174-80.
23. Svendsen UG, Frolund L, Heinig JH, Madsen F, Nielsen NH, Weeke B. [High dose inhaled steroids in the treatment of bronchial asthma. A comparison of the effects of budesonide and beclomethasone dipropionate on pulmonary function, symptoms, bronchial reactivity and adrenocortical function]. Ugeskrift for Laeger 1993;155(28):2197-202.
24. Tjwa MK. Budesonide inhaled via Turbuhaler: a more effective treatment for asthma than beclomethasone dipropionate via Rotahaler. Annals of Allergy, Asthma & Immunology 1995;75(2):107-11.
25. Willey RF, Godden DJ, Carmichael J, Preston P, Frame MH, Crompton GK. Twice daily inhalation of a new corticosteroid, budesonide, in the treatment of chronic asthma. European Journal of Respiratory Diseases - Supplement 1982;122:138-42.
26. Birkebaek NH, Esberg BH, Andersen K, Wolthers OD, Hassager C. [Budesonide and beclomethasone dipropionate inhalation powders. The effect on bone and collagen turnover in children]. Ugeskrift for Laeger 1997;159(17):2559-62.
27. Bjorkander J, Formgren H, Johansson SA, Millqvist E. Methodological aspects on clinical trials with inhaled corticosteroids: results of two comparisons between two steroid aerosols in patients with asthma. European Journal of Respiratory Diseases - Supplement 1982;122:108-17.
28. de GraaffCS, van der Burgh JHAM, Stallaert RALM, Prins J, van Lier AA. A double-blind comparative study of the inhaled corticosteroids budesonide and beclomethasone dipropionate in dry powder inhalers in asthmatic patients. European Respiratory Journal. 1996; Vol. 5, issue Suppl 15:S359-60.
29. Kiviranta K, Turpeinen M. Effect of eight months of inhaled beclomethasone dipropionate and budesonide on carbohydrate metabolism in adults with asthma. Thorax 1993;48(10):974-8.
30. Piquet J, Zuck P, Dennewald G, Dugue P, Grivaux M, Brun P, et al. Equally efficacious asthma management with budesonide 800 mug administered by Turbuhaler(TM) or with beclomethasone dipropionate >=1500 mug given through a pressurized metered-dose inhaler with spacer. Advances in Therapy 1996;13(1):38-50.
31. Rosenhall L, Lundqvist G, Adelroth E, Glennow C. Comparison between inhaled and oral corticosteroids in patients with chronic asthma. European Journal of Respiratory Diseases - Supplement 1982;122:154-62.
32. Struijs A, Mulder H. The effects of inhaled glucocorticoids on bone mass and biochemical markers of bone homeostasis: a 1-year study of beclomethasone versus budesonide. Netherlands Journal of Medicine 1997;50(6):233-7.
33. Baxter-Jones AD, Helms PJ. Early introduction of inhaled steroids in wheezing children presenting in primary care. A pilot study. Clinical & Experimental Allergy 2000;30(11):1618-26.
34. Brand PL, van der Baan-Slootweg OH, Heynens JW, de Vries TW, Versteegh FG, Vreuls RC, et al. Comparison of handling and acceptability of two spacer devices in young children with asthma. Acta Paediatrica 2001;90(2):133-6.
35. Dal Negro R, Micheletto C, Tognella S, Mauroner L, Burti E, Turco P, et al. Effect of inhaled beclomethasone dipropionate and budesonide dry powder on pulmonary function and serum eosinophil cationic protein in adult asthmatics. Journal of Investigational Allergology & Clinical Immunology 1999;9(4):241-7.
36. Hernandez J, Garcia-Selles FJ, Negro JM, Pascual A, Sola J, Miralles JC, et al.[Comparative study] of beclomethasone and budesonide, with same posology (400 micrograms every 12 hours), in the control of cortico- dependent intrinsic asthma]. Allergologia et Immunopathologia 1995;23(5):193-201.
37. Jager L, Laurikainen K, Leinonen M, Silvasti M. Beclomethasone dipropionate Easyhaler is as effective as budesonide Turbohaler in the control of asthma and is preferred by patients. International Journal of Clinical Practice 2000;54(6):368-72.
38. Kraszko P, Vondra D, Malolepszy J, Svensson M, Baly J, Fiserova J, et al. Budesonide via Turbuhaler, 400 mug daily, is as effective as beclomethasone dipropionate via pressurised MDI, 800 mug daily, for control of mild to moderate asthmatic patients. Journal of Clinical Research 1999;2:47-55.
39. Lee YC, Rhee YK. Effect of inhaled steroids on the cortisol concentration by different dosage or delivery method. Tuberculosis & Respiratory Diseases 1995;42(6):888-99.
40. Reichel W, Dahl R, Ringdal N, Zetterstrom O, van den Elshout FJ, Laitinen LA. Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma. International Journal of Clinical Practice 2001;55(2):100-6.
41. Boobis AR. Comparative physiochemical and pharmacokinetic profiles of inhaled beclomethasone dipropionate and budesonide. Respiratory Medicine 1998;92(Suppl B):2-6.
42. British Thoracic Society. The British guidelines on asthma management 1995 review and position statement. Thorax 1997;52(Suppl 1):S1-20.
43. National Asthma Education and Prevention Program. Global strategy for asthma management and prevention NHBLI/WHO workshop report. Bethesda MD: NIH/National Heart, Lung and Blood Institute 1995, issue Publication No. 95-3659.
44. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17(1):1-12.
45. Johansson SA, Andersson KE, Brattsand R, Gruvstad E, Hedner P. Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in man. European Journal of Clinical Pharmacology 1982;22:523-9.
46. National Asthma Education and Prevention Program. Guidelines for the Diagnosis and Managment of Asthma, Expert Panel Report No. 2. Bethesda MD: NIH/National Heart, Lung and Blood Institute 1997, issue NIH Publication No. 97-4051.
47. Pethica BD, Penrose A, MacKenzie D, Hall J, Beasley R, Tilyard M. Comparison of potency of inhaled beclomethasone and budesonide in New Zealand: retrospective study of computerised general practice records. BMJ 1998;317(7164):986-90.
48. Stellato C, Atsuta J, Bickel CA, Schleimer RP. An in vitro comparison of commonly used topical glucocorticoid preparations. Journal of Allergy & Clinical Immunology 1999;104(3 Pt 1):623-9.